Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab

Journal of Neuro-Oncology(2024)10.1007/s11060-023-04551-9Source: DataRank Database

The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab is a research paper published in Journal of Neuro-Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (19)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Alexander Ou,Heather Lin ORCID,Timothy A. Gregory ORCID,Kristin Alfaro-Munoz ORCID,Ying Yuan ORCID

Live enrichment

PubMed:38372903 PMC:PMC11758674

National Institutes of Health/National Cancer Institute

Grant: P30CA016672

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11758674/pdf/nihms-2048650.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11060-023-04551-9.pdf

publisherhttps://link.springer.com/article/10.1007/s11060-023-04551-9/fulltext.html

https://doi.org/10.1007/s11060-023-04551-9

https://pubmed.ncbi.nlm.nih.gov/38372903

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansGliomaBrain NeoplasmsRisk FactorsRetrospective StudiesVenous ThromboembolismBevacizumab

Keywords

Intracerebral hemorrhageVenous ThromboembolismBevacizumabHigh-grade GliomaCerebral MacrobleedingRisk FactorsBrain NeoplasmsHumansGliomaRetrospective Studies